Premium
Agios Pharmaceuticals Inc (AGIO)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' p... Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. Show more
– Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session – – Tebapivat Phase 1 Data in Sickle Cell Disease and Phase 2b...
– Completed Enrollment of the Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease; Topline Data from 52-Week Study Expected in Late 2025 – – Received $1.1 Billion in Payments from Royalty...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.59 | 1.02805366789 | 57.39 | 59.86 | 56.67 | 421482 | 58.95355856 | CS |
| 4 | 13.44 | 30.1751234845 | 44.54 | 62.58 | 43.25 | 723368 | 55.92126134 | CS |
| 12 | 13.78 | 31.1764705882 | 44.2 | 62.58 | 39.94 | 593229 | 49.32185153 | CS |
| 26 | 21.11 | 57.2552210469 | 36.87 | 62.58 | 36.39 | 597692 | 47.26070548 | CS |
| 52 | 35.15 | 153.964082348 | 22.83 | 62.58 | 20.96 | 681062 | 36.81914147 | CS |
| 156 | 22.08 | 61.504178273 | 35.9 | 62.58 | 16.75 | 605956 | 30.3227788 | CS |
| 260 | 19.53 | 50.7932379714 | 38.45 | 62.58 | 16.75 | 637246 | 37.32757417 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
